Action 603658 AUTOBIO DIAGNOSTICS CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Autobio Diagnostics Co., Ltd.

Actions

603658

CNE100002GC4

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
56,35 CNY +0,21% Graphique intraday de Autobio Diagnostics Co., Ltd. +3,81% -1,16%
19/04 Les bénéfices d'Autobio Diagnostics au premier trimestre augmentent de 34%. MT
19/04 Le bénéfice 2023 d'Autobio Diagnostics grimpe de 4 % alors que le revenu d'exploitation reste stable MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Autobio Diagnostics' Q1 Profit Jumps 34%
Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.
Autobio Diagnostics Secures Registration Certificates for 11 Devices
Autobio Diagnostics Gets Regulatory Nod in China for 16 Devices
Autobio Diagnostics Co., Ltd. commences an Equity Buyback Plan for CNY 500 million worth of its shares, under the authorization approved on February 20, 2024.
Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan.
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to S&P Global BMI Index
Autobio Diagnostics Logs Low Single-Digit Earnings Growth in H1
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Autobio Diagnostics Gets Registration Certificates for Five Devices
Shenzhen Meili Namikong Technology Co., Ltd. announced that it has received funding from Autobio Diagnostics Co., Ltd.
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to FTSE All-World Index
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.'s Equity Buyback announced on March 19, 2022, has closed with 5,260,910 shares, representing 0.90% for CNY 243.27 million.
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 603658
  4. Actualités Autobio Diagnostics Co., Ltd.
  5. Autres langues